Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
2 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 139.00 | |
25 mg | In stock | $ 278.00 | |
50 mg | In stock | $ 447.00 | |
100 mg | In stock | $ 713.00 | |
200 mg | In stock | $ 987.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma. |
Synonyms | SHP-141 |
Molecular Weight | 323.34 |
Formula | C16H21NO6 |
CAS No. | 946150-57-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (463.91 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Remetinostat 946150-57-8 Chromatin/Epigenetic DNA Damage/DNA Repair HDAC Inhibitor SHP141 SHP-141 inhibit Histone deacetylases SHP 141 inhibitor